A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea

BMC Infectious Diseases

Research

Tae Sun Shim¹  Yong-Soo Kwon²  Jae Chol Choi³  JaeSeok Park⁴  Ji Hyun Kim⁵  Hyeongyeong Kim⁵  Lori Alquier⁶  Helen Pai⁶  Eileen Birmingham⁶  Kourtney Davis⁷  Nyasha Bakare⁷  Gary Mao⁷  Florence Thoret-Bauchet⁸  Seung Heon Lee⁹  JeongHa Mok^1,10 

[1] Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea;Chung-Ang University Hospital, Seoul, South Korea;Dankook University Hospital, Cheonan, South Korea;Janssen Korea, Seoul, South Korea;Janssen Research and Development, LLC, Raritan, NJ, USA;Janssen Research and Development, LLC, Titusville, NJ, USA;Janssen-Cilag, Issy-Les-Moulineaux, France;Korea University Ansan Hospital, Ansan, South Korea;Pusan National University Hospital, Busan, South Korea;

关键词: Tuberculosis;    Multidrug-resistant;    Bedaquiline;    South Korea;   

DOI  :  10.1186/s12879-022-07955-6

 received in 2022-05-31, accepted in 2022-12-19,  发布年份 2022

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

12888_2022_4443_Article_IEq5.gif

41116_2022_35_Article_IEq421.gif

41116_2022_35_Article_IEq419.gif

41116_2022_35_Article_IEq416.gif